Automatic production of personalized medicines through pharmaceutical 3D printing
Improved healthcare for patients
Every patient is different
Every medication should be different
With over 8 years of expertise in pharmaceutical 3D printing, MB Therapeutics, a company based in Montpellier, France, offers a solution for manufacturing personalized medicine through healthcare 3D printing.
A patient centric solution
We offer a patient-centric solution to develop and produce personalized medicines through 3D printing, allowing dosage customization, customized forms, and the ability to combine multiple active ingredients within a single medication.
Is my molecule printable?
Let’s discuss its printability!
By discussing its physicochemical properties, we can provide you with an evaluation of its printability and determine which pharmaceutical 3D printing technology is best suited for it.
Innovation serving patients
We offer a patient-centered solution to develop and produce personalized medicines through pharmaceutical 3D printing, allowing dosage customization, customized forms, and the combination of multiple active ingredients within a medication.
« Pharmaceutical 3D printing enables on-demand medication delivery in clinical trial centers: customized doses directly on-site with shorter availability times compared to currently available on-site processes. »
Clinical Study Manager, Sanofi
« The MB Therapeutics solution can provide a real improvement in quality of life and thus enhance treatment adherence for patients. »
Marc Daumas, Ex. Innovation Manager, Sanofi
« The MB Therapeutics technology combines the benefits of solid and liquid forms, allowing the production of unit doses and dosage variability, without the drawbacks associated with liquid forms. »
Ian Soulairol, Hospital Pharmacist
« 3D printing medicines is highly useful in the industry to accelerate the Phase 2A stage and thus limit investments prior to this phase (80% of projects fail after Phase 2A). »
Production manager, Sanofi
The Public Investment Bank grants MB Therapeutics a subsidy for the development of next-generation drugs.
MB Therapeutics Expands its Team with the Arrival of Léna Lemierre, an Expert in Pharmaceutical 3D Printing
Discover how Léna Lemierre, an expert in pharmaceutical 3D printing, is accelerating the development of personalized medicine.
Comparison of Gel Extrusion Technologies: Piston, Air and Screws, for the Manufacture of Personalized Medicines
Discover the different 3D printing technologies of pharmaceutical gels to produce personalized medicines.
The seed fund Créalia awards an innovation grant to MB Therapeutics for the development of its personalized medicine solution.